Clinical Trial Update: Xeltis Hemodialysis Access (aXess) Conduit: aXess-E Study [NA]

View source ↗

Summary

Clinical trial update indicates that the aXess-E study evaluating Xeltis' aXess Hemodialysis Access conduit for End-stage renal disease is currently recruiting.…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• aXess

Snippet

Sponsor: Xeltis | Conditions: End Stage Renal Disease | NA | Status: RECRUITING